A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 3.27 EUR 2.19% Market Closed
Market Cap: 248.3m EUR
Have any thoughts about
Atrys Health SA?
Write Note

Intrinsic Value

The intrinsic value of one ATRY stock under the Base Case scenario is 5.33 EUR. Compared to the current market price of 3.27 EUR, Atrys Health SA is Undervalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATRY Intrinsic Value
5.33 EUR
Undervaluation 39%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation Backtest
Atrys Health SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ATRY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ATRY?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Atrys Health SA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Atrys Health SA

Provide an overview of the primary business activities
of Atrys Health SA.

What unique competitive advantages
does Atrys Health SA hold over its rivals?

What risks and challenges
does Atrys Health SA face in the near future?

Has there been any significant insider trading activity
in Atrys Health SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Atrys Health SA.

Provide P/S
for Atrys Health SA.

Provide P/E
for Atrys Health SA.

Provide P/OCF
for Atrys Health SA.

Provide P/FCFE
for Atrys Health SA.

Provide P/B
for Atrys Health SA.

Provide EV/S
for Atrys Health SA.

Provide EV/GP
for Atrys Health SA.

Provide EV/EBITDA
for Atrys Health SA.

Provide EV/EBIT
for Atrys Health SA.

Provide EV/OCF
for Atrys Health SA.

Provide EV/FCFF
for Atrys Health SA.

Provide EV/IC
for Atrys Health SA.

Show me price targets
for Atrys Health SA made by professional analysts.

What are the Revenue projections
for Atrys Health SA?

How accurate were the past Revenue estimates
for Atrys Health SA?

What are the Net Income projections
for Atrys Health SA?

How accurate were the past Net Income estimates
for Atrys Health SA?

What are the EPS projections
for Atrys Health SA?

How accurate were the past EPS estimates
for Atrys Health SA?

What are the EBIT projections
for Atrys Health SA?

How accurate were the past EBIT estimates
for Atrys Health SA?

Compare the revenue forecasts
for Atrys Health SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Atrys Health SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Atrys Health SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Atrys Health SA compared to its peers.

Compare the P/E ratios
of Atrys Health SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Atrys Health SA with its peers.

Analyze the financial leverage
of Atrys Health SA compared to its main competitors.

Show all profitability ratios
for Atrys Health SA.

Provide ROE
for Atrys Health SA.

Provide ROA
for Atrys Health SA.

Provide ROIC
for Atrys Health SA.

Provide ROCE
for Atrys Health SA.

Provide Gross Margin
for Atrys Health SA.

Provide Operating Margin
for Atrys Health SA.

Provide Net Margin
for Atrys Health SA.

Provide FCF Margin
for Atrys Health SA.

Show all solvency ratios
for Atrys Health SA.

Provide D/E Ratio
for Atrys Health SA.

Provide D/A Ratio
for Atrys Health SA.

Provide Interest Coverage Ratio
for Atrys Health SA.

Provide Altman Z-Score Ratio
for Atrys Health SA.

Provide Quick Ratio
for Atrys Health SA.

Provide Current Ratio
for Atrys Health SA.

Provide Cash Ratio
for Atrys Health SA.

What is the historical Revenue growth
over the last 5 years for Atrys Health SA?

What is the historical Net Income growth
over the last 5 years for Atrys Health SA?

What is the current Free Cash Flow
of Atrys Health SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Atrys Health SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Atrys Health SA

Current Assets 93.2m
Cash & Short-Term Investments 23m
Receivables 65.1m
Other Current Assets 5.1m
Non-Current Assets 509.9m
Long-Term Investments 6.2m
PP&E 59.6m
Intangibles 434.6m
Other Non-Current Assets 9.5m
Current Liabilities 95.2m
Accounts Payable 19.9m
Accrued Liabilities 321k
Other Current Liabilities 75m
Non-Current Liabilities 236.7m
Long-Term Debt 197.5m
Other Non-Current Liabilities 39.2m
Efficiency

Earnings Waterfall
Atrys Health SA

Revenue
190.8m EUR
Cost of Revenue
-63.1m EUR
Gross Profit
127.6m EUR
Operating Expenses
-126m EUR
Operating Income
1.7m EUR
Other Expenses
-40.7m EUR
Net Income
-39.1m EUR

Free Cash Flow Analysis
Atrys Health SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ATRY Profitability Score
Profitability Due Diligence

Atrys Health SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
37/100
Profitability
Score

Atrys Health SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

ATRY Solvency Score
Solvency Due Diligence

Atrys Health SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
28/100
Solvency
Score

Atrys Health SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATRY Price Targets Summary
Atrys Health SA

Wall Street analysts forecast ATRY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRY is 6.16 EUR with a low forecast of 5.05 EUR and a high forecast of 6.83 EUR.

Lowest
Price Target
5.05 EUR
54% Upside
Average
Price Target
6.16 EUR
88% Upside
Highest
Price Target
6.83 EUR
109% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ATRY?

Click here to dive deeper.

Dividends

Atrys Health SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ATRY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ATRY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Atrys Health SA

Country

Spain

Industry

Health Care

Market Cap

248.3m EUR

Dividend Yield

0%

Description

Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. The company is headquartered in Madrid, Madrid and currently employs 2,397 full-time employees. The company went IPO on 2016-07-22. The company operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. The company has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The firm has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.

Contact

MADRID
Madrid
C/ Principe de Vergara 132, 1 piso
+34934581561
www.atryshealth.com

IPO

2016-07-22

Employees

2 397

Officers

Executive Chairman
Mr. Santiago De Torres Sanahuja
CEO & Executive Director
Ms. Isabel Lozano Fernandez
Founder & Scientific Vice President
Dr. Carlos Cordon-Cardo
Founder and Medical Vice President
Dr. Zvi Fuchs
Chief Financial Officer
Mr. Jose Maria Huch Ginesta
Global Chief Technology Officer
Luis Duran
Show More
Administration Director
Encarna Vega
Head of Investor Relations
Ms. Maria Marin
General Counsel
Ms. Gabriela Camunas
People Director
Pedro Salord
Show Less

See Also

Discover More
What is the Intrinsic Value of one ATRY stock?

The intrinsic value of one ATRY stock under the Base Case scenario is 5.33 EUR.

Is ATRY stock undervalued or overvalued?

Compared to the current market price of 3.27 EUR, Atrys Health SA is Undervalued by 39%.

Back to Top